DudeDiligence.

Valion Bio, Inc

VBIONASDAQ · Pharmaceutical Preparations
Write an idea

Financing

Shares on issue

4.15M

From 364K in June 2024

Earlier counts are in today's shares, after the 1-for-17 reverse split; each bar's tip shows the count as filed.

a raise that quarter, at its price

Newest

$100.0M

S-3 of 2026-10-08. Sales under the at-the-market programme filed with it are not stated apart.

$5.0M

Rodman & Renshaw, agreement of 2026-10-07. No at-the-market sales on file.

Warrants

3.96M

Priced warrants: 3.96M at $0.62, $2.231, $3.26, $3.52, $3.64, $3.80, $4.20, $14.45, $15.90, $81.60, $83.64, $112.20, $531.25, $1768.00, $10625.00.

Cash

0.6 quarters

$2.1M cash on hand.

Raised
DateWhatSharesPriceGrossFiling
2026-11-09Private placement21,539not available$700K8-K ↗
2026-10-27Private placement1,539not available$50K8-K ↗
2026-10-08Private placement1,539not available$50K8-K ↗
2026-09-01Private placement3,077not available$7.7M8-K ↗
2026-08-17Private placementnot availablenot available$1.5M8-K ↗

Also on file: a going-concern note in the 10-Q filed 2026-08-14 10-Q ↗